06.12.2017
Positive preclinical results for the active ingredient in VAL-63-NAFLD on non-alcoholic fatty liver, a risk factor for NASH
Download
04.12.2017
Metformin + TOTUM-63 combination: first positive preclinical data for possible use in diabetes real life practice
Download
08.11.2017
VALEDIA®: launch of “pivotal” REVERSE-IT clinical trial to obtain a health claim
Download
16.10.2017
LIPIDRIVE®: efficacy confirmed in three models, finalization of recruitment for Phase I/II in humans
Download
20.09.2017
International pharmaceutical and nutrition expert Dr. Jean Zetlaoui joins VALBIOTIS’ Supervisory Board
Download
05.09.2017
VALBIOTIS opens a new Clinical Investigation Center at the Institut Pasteur in Lille as part of the Phase IIa study on TOTUM-63, the active ingredient of Valedia®
Download